DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Kubitza D. et al.
Body weight has limited influence on the safety, tolerability, pharmacokinetics, or pharmacodynamics of rivaroxaban (BAY 59–7939) in healthy subjects..
J Clin Pharmacol 2007;
47: 218-226.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.